Collegium Announces $35 Million Accelerated Share Repurchase Program
Collegium Announces $35 Million Accelerated Share Repurchase Program
Collegium downgraded by Piper Sandler over valuation
Collegium Pharmaceutical Reports First Quarter 2024 Earnings
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA)
Collegium Pharmaceutical CEO Joe Ciaffoni Steps Down
Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
Collegium Announces CEO Transition
Collegium Reports First Quarter 2024 Financial Results
Collegium Announces CEO Transition
Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics
Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.